1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Program in Health Equity and Population Health Seed Grant Program is sponsored by University of Maryland School of Medicine. This program provides seed funding for projects focused on innovative research in health equity and population health.
While not exclusively focused on Clostridioides difficile, research projects addressing infectious diseases and their impact on population health could be relevant, especially if they involve health disparities or community-engaged approaches.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Faculty members at the University of Maryland School of Medicine, particularly those with projects involving bidirectional partnerships with community advisors. Confirm the full requirements in the official notice before applying.
The current listing shows up to $25,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Program in Health Equity and Population Health Seed Grant Program is funded by University of Maryland School of Medicine. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Maryland. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Hopkins expanded its Pivot and Bridge program from $12.5M to $60M annually, raised the per-award cap to $250K, and dropped the divisional match requirement. Maryland chipped in $8.5M. The structure tells you where private bridge-funding is heading.
Read articleThe full ASPECT NOFO (DE-FOA-0003647) posted September 4, 2026, eleven days later than the Notice of Intent predicted. The real document splits $58 million across two topic areas with anticipated award counts of 0-7 and 0-3, a cost share that jumps from 20 percent to 50 percent mid-project, a mandatory five-page concept paper due October 9, and a university eligibility restriction that decides team structure before anyone writes a word.
Read articleDARPA pre-released Release 6 of its FY26 SBIR BAA on September 2, 2026. Five of the seven SBIR topics belong to the Biological Technologies Office, and four of those describe one continuous problem: keeping a casualty alive with no surgeon, no imaging, and no evacuation. Here are the award sizes, the Direct-to-Phase-II gates, and the sequencing DARPA is buying.
Read article